The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate. The FDA approved Eli Lilly ...
In a new study, researchers examined the health effects people experienced when they returned to still-standing homes after ...
A look back at the horrible loss of life. By Hannah Beech A global crackdown on fentanyl has led cartels to innovate production methods and test their risky formulas on people, as well as ...
The Waverley Council says it will consider taking actions after tens of thousands of people trashed Sydney's Bronte Beach following a massive Christmas party. Tens of thousands of people have ...
The main opposition Democratic Party (DP) submitted an impeachment motion against acting President Han Duck-soo and reported it to a parliamentary plenary session Thursday. The ... The ...
The United States Food and Drug Administration (FDA) has approved the weight-loss drug Tirzepatide — sold by the brand name ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback